Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) CFO Jack Anders sold 35,750 shares of Revolution Medicines stock in a transaction dated Wednesday, November 11th. The shares were sold at an average price of $188.10, for a total transaction of $6,724,575.00. Following the sale, the chief financial officer directly owned 119,216 shares in the company, valued at $22,424,529.60. The trade was a 23.07% decrease in their position. The sale w…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.